FONT-SIZE Plus   Neg

FDA Approves Abbott's FreeStyle InsuLinx Blood Glucose Monitoring System

Abbott Laboratories (ABT) announced that it has received U.S. Food and Drug Administration clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System.
The company said that the system included a touch-screen interface, automated logbook. The system also offers Personalization features, including the ability to upload weekly messages, pre-and post-meal markers and a personal photograph to the home screen.

This unique device is also equipped with built-in FreeStyle Auto-Assist software that enables patients to track progress, analyze trends and easily display data for their health care providers.

The FreeStyle InsuLinx System will be available to U.S. consumers within the coming months, the company said.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Software giant Microsoft Corp. (MSFT), Tuesday reported a profit for the first quarter that trumped analysts' estimates, as CEO Satya Nadella's strategy seems to be working reflected by strong growth in cloud business. Microsoft stock spiked up over 5 percent in after hours trading. Redmond, Washington-based... In order to make Facebook more user-friendly, the social media giant introduced a few attractive new features. Recommendation tool, call-to-action buttons, and new section pages are expected to attract more users in a world where there are more mobiles than human beings. Starbucks Coffee Co. said Thursday that it plans to open a Reserve Roastery in Japan in 2018. This will be the coffee giant's fourth Roastery location globally. The new location will be located in Tokyo's upscale Nakameguro district, known for its exclusive boutiques and art galleries.
comments powered by Disqus
Follow RTT